This week there were 24 Top Picks and 3 ETF in a wide range of industries: ETF, Financials, Technology, Healtcare, Consumer, Basic Materials, Industrials, Energy, Telecommunications and Utilities.
Here are this week’s Top Picks as selected by: David Cockfield, Fabrice Taylor, James Hodgins, Brooke Thackray, Michael Sprung, Ryan Bushell, Jaime Carrasco, Robert McWhirte, Michael Simpson and David Driscoll.
If you have a growth part of your portfolio, it should be in the TFSA. You want maximum growth in TFSA so he would not recommend it for these accounts.
Get similar or better returns with less risk, beta, volatility. Well constructed product. Skews more to certain sectors like utilities and financial services, so you'll see underperformance. For 5-10-15-20 years, it's a thoughtful way to get returns from the market. Try XMV, which creates a portfolio of minimum volatility. You could use these 2 ETFs…
Small cap stocks in the US. It has been hit the hardest. It is a great place to come out of this. Buy it lower than today.
Canadian banks are under huge pressure with rates so low. Possible that rates go negative next year, and that's a tax on fixed income. One of Canada's strongest banks, along with Royal. They'll figure out a way to make money, no matter what the environment.
He owns many Canadian banks. Pays a higher dividend than peers and is exposed to Latin America, which offers growth. The Canadian banking sector is undervalued and offers dividend growth. Banks are well capitalized and in great shape.
(A Top Pick Jan 30/20, Down 4%) They have been so desperate for a steepening yield curve. Stocks have already started to respond to this. Buying this with a dividend of 4%+ dividend yield. They are poised to rebound.
Populated by public and private investments in India. One stock he would tuck away for 10 years. India is the largest democracy, and corporate tax cuts have been encouraging. Fundamentals are looking great for India.
He has been investing in this for almost three years now. They received Health Canada approval for a new brain stimulation medical device last fall. They are awaiting FDA approval in the US. It magnifies the result of physio-therapy for the brain and the technology is safe. It is a billion dollar business if it…
90% of the things they make are disposables. They make syringes among other things. The products are diversified and one does not dominate their revenues. There are many operations that should have happened but have not due to covid. Earnings will accelerate once covid has subsided and procedures restart.
A fine long-term performer. They bought a biopharma asset from GE and will report on it in on Wednesday.
They own a series of food distribution businesses. It appears they are not making any money from them. It appears to be a scale problem.
Covid could be a great long-term opportunity for TJX, because they buy clothes and other products from distressed merchants, but short-term he doesn't see many customers, because they don't sell essential, must-have items during this pandemic. He expects a disappointing quarter. They report next week.
Will it hit $12.50? Hasn't researched this name. He just knows their main mine is in Mali where there's political uncertainty and jurisdictional risk. Are investors compensated for this risk? Is the stock cheap enough? He can't tell what the price target is.
(A Top Pick Jan 14/19, Up 7%) Strong seasonality in January to May, but it does really poorly in May to October. It plunged in late-2018 and has recovered since late-2018, but slower than the overall market. It's merely okay now.
(A Top Pick Jan 06/20, Up 10%) Very strong global agri company that you can't find anywhere else. Paused dividend last year. Should see it increase in 2021. Headwinds have turned into tailwinds. Good diversifier in portfolios. Yield is 4-4.5%.
It's a work in progress royalty company in gold and precious metals. Only three years old, it's very active by deploying $70 million of capital. Only two of their 45 assets are actually producing with two more coming on this year. So, there'll be a rapid advance in cash flow. The dividend is small but…
Airlines continue to struggle and will take much longer than some expect to recover. There are better opportunities in other sectors, like metals. Yes, people want to travel again, but he thinks it will be a long while before people can actually travel, especially for business.
(A Top Pick Jan 17/19, Up 68%) This is artificial intelligence that is replacing people in call centres. These are insurance and financial call centres. He expects there to still be a long runway to come. This trades in France.
(A Top Pick Jan 17/19, Down 7%) He blames the CFO for the loss. They were signing contracts that were not compliant and their guidance was off. Even though the stock is down, if they have earnings of 3.20 per share range, the stock is fully valued. If they make 4.20 next year, the stock…
They're in northeast BC where Tourmaline is consolidating land and assets, near LXE. So, LXE will become topical. LXE has reached an inflection point after acquiring a lot of land and pushed the Montney play to the northeast. Now, they need a lot of capital to move to full development. They're talking to potential buyers,…
She does not think a cancellation of the XL project will impact this company. They will still grow their dividend. The news is a negative sentiment action on the stock price.
Their balance sheet needs to be fixed, assets are scattered all over the world so operational focus is difficult. Their valuation is not compelling compared to other names. He has been a sell for years.
It's fine, but not his top pick in the telco space. Low beta. Less of a yield than others. A defensive, work from home play. Some of the bloom may come off the work from home trade, and money may flow to more cyclical parts of the market.
Billy Kawasaki’s Insights - Billy’s most-liked answers from 5i Research. The Biden win was probably fully priced in so that accounts for the slight pullback recently. The stocks are up 50% this year. Sector rotation is also a factor and investors may be switching out for underperforming stocks. No real concern and both companies remain…
All dividend stocks should continue to benefit from low interest rates. If we see the economic recovery that might come next year, you could see increased demand for stocks like this. If they can't get yields from GICs, people will look to dividend stocks. He can't say specifically if this particular stock will continue to…
It is a boring utility, regulated. Dividend just under four percent. They have defensible cash flow streams. She likes the dividend growth. The payout ratio is very reasonable at 65% of cash flow. (Analysts’ price target is $57.93)